Clinical Trials on Lung Transplant Failure and Rejection in Japan
Total 1256 results
-
AstraZenecaCompletedLocally Advanced or Metastatic NSCLCKorea, Republic of, China, Japan
-
Novartis PharmaceuticalsTerminatedAcute Heart FailureIndia, Taiwan, Japan, Korea, Republic of, Thailand, Lebanon, Philippines, China, Malaysia, Singapore, Jordan
-
GlaxoSmithKlineCompleted
-
Deep BreezeCompletedCentral Airway StenosisUnited States, France, Germany, Japan
-
PfizerTerminatedNon-Small Cell Lung CancerUnited States, Korea, Republic of, Australia, Japan
-
PfizerTerminatedGastric Cancer | Non Small Cell Lung Cancer | Advanced Solid Tumors | Gastroesophageal Junction Cancer | Urothelial Cancer | Head and Neck Squamous Cell CarcinomasUnited States, Japan
-
Mylan Inc.CompletedDigestive System Diseases | Pancreatic Diseases | Cystic Fibrosis | Exocrine Pancreatic InsufficiencyJapan
-
Incyte Biosciences Japan GKRecruiting
-
Astellas Pharma Global Development, Inc.CompletedCytomegalovirus (CMV)-Positive Recipients | Allogeneic, Hematopoietic Cell Transplant (HCT)Japan, Korea, Republic of, United States, Canada, Australia, Belgium, France, Germany, Spain, Sweden, Taiwan
-
AbbVieRecruitingNon-Small Cell Lung CancerUnited States, Israel, Japan, Taiwan
-
AmgenRecruitingSmall-Cell Lung Cancer | Extensive-Stage Small-Cell Lung CancerUnited States, China, Japan, Switzerland, Turkey
-
GlaxoSmithKlineActive, not recruiting
-
Novartis PharmaceuticalsCompleted
-
Merck Sharp & Dohme LLCActive, not recruiting
-
Eli Lilly and CompanyMerck Sharp & Dohme LLCCompletedStage IV Non-Small Cell Lung CancerSpain, United States, France, Japan
-
GlaxoSmithKlineCompletedAsthmaJapan, United States, United Kingdom, Poland
-
Merck Sharp & Dohme LLCRecruitingNon-small Cell Lung Cancer | Solid Tumors | Programmed Cell Death-1 (PD1, PD-1) | Programmed Cell Death 1 Ligand 1(PDL1, PD-L1) | Programmed Cell Death 1 Ligand 2 (PDL2, PD-L2)Japan
-
GlaxoSmithKlineCompletedRhinitis, Allergic, PerennialJapan
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedPulmonary HypertensionJapan
-
Novartis PharmaceuticalsCompletedAllergic AsthmaJapan
-
Janssen Pharmaceutical K.K.RecruitingPulmonary Arterial HypertensionJapan
-
Novartis PharmaceuticalsTerminatedAdvanced Solid TumorSpain, Singapore, Japan, United States, Canada
-
Eli Lilly and CompanyICOS CorporationCompletedHypertension, PulmonaryUnited States, Belgium, Canada, France, Germany, Ireland, Italy, Japan, Spain, United Kingdom
-
Toronto Rehabilitation InstituteCanadian Institutes of Health Research (CIHR); Philips RespironicsTerminatedHeart Failure | Sleep ApneaCanada, Spain, Japan, Germany, France, United States, Brazil, Italy, United Kingdom
-
Daiichi SankyoRecruitingNon-Small Cell Lung Cancer (NSCLC)United States, Korea, Republic of, Spain, Japan, Netherlands, Taiwan
-
AstraZenecaActive, not recruitingCarcinoma, Non-Small-Cell Lung | Small Cell Lung Carcinoma | Carcinoma, Squamous Cell of Head and NeckUnited States, Taiwan, Korea, Republic of, Japan, Spain
-
AbbVieRecruitingNon Small Cell Lung CancerCanada, United Kingdom, Argentina, Japan, Switzerland
-
AstraZenecaCompletedPulmonary Disease, Chronic ObstructiveJapan
-
PfizerTerminatedNon-Small Cell Lung CancerUnited States, Australia, Japan, Korea, Republic of, Spain
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseJapan
-
Novartis PharmaceuticalsCompletedAdvanced Non-small Cell Lung CancerSpain, Canada, Germany, Korea, Republic of, Taiwan, United States, Japan, Netherlands, Singapore
-
PfizerCompletedALK-positive Non-small-cell Lung CancerJapan
-
Osaka General Medical CenterWakayama Medical University; Nagasaki University; University of the Ryukyus; Kansai... and other collaboratorsCompletedVentilator Associated PneumoniaJapan
-
St. Justine's HospitalUniversity of Maryland, College Park; Tokyo Women's Medical University; Tokyo... and other collaboratorsEnrolling by invitationAcute Respiratory Distress Syndrome | Medical Emergencies | Distress Respiratory Syndrome | Chemical Injury | Chemicals; IntoxicationCanada, France, Japan, United States
-
AmgenAvailableSmall Cell Lung CancerUnited States, Brazil, Japan
-
AmgenActive, not recruitingSmall Cell Lung CancerUnited States, Belgium, Austria, Singapore, Taiwan, Japan
-
AstraZenecaCompleted
-
Ology BioservicesBaxter Innovations GmbHCompleted
-
AstraZenecaCompleted
-
Boston Scientific CorporationICON plcCompletedHeartfailureSpain, Belgium, Netherlands, Hong Kong, Italy, France, Finland, Switzerland, Israel, Germany, United Kingdom, Colombia, Singapore, Denmark, Portugal, Japan, Austria, Ireland
-
AstraZenecaCompletedPart A and B: Advanced Solid Malignancies | Part C: Malignant MesotheliomaJapan
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsTerminatedCarcinoma, Non-Small-Cell LungBelgium, Germany, United States, Canada, France, Italy, Japan, Korea, Republic of, Spain
-
TakedaActive, not recruitingNon-Small Cell Lung CancerJapan
-
Eli Lilly and CompanyAlkermes, Inc.Completed
-
KK Women's and Children's HospitalNational University Hospital, Singapore; Ramathibodi Hospital; Universiti Kebangsaan... and other collaboratorsCompletedCOVID | Pediatric DisorderSingapore, Pakistan, Malaysia, India, China, Indonesia, Japan